AURA
Aura Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.56
+2.58%0
Insider buys (3m)
1
Insider sells (3m)
-$82.3K
Net value (3m)
+12.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Elazzouzi Amy · officer: SVP, Finance & PAO | A-Award | 23,540 | $0.00 |
| Sep 1, 2026 | Person Julie · officer: Chief People Officer | A-Award | 107,611 | $0.00 |
| Sep 1, 2026 | Person Julie · officer: Chief People Officer | A-Award | 212,389 | $7.43 |
| Sep 1, 2026 | Kratz Erica · officer: Chief Reg. & Quality Officer | A-Award | 100,885 | $0.00 |
| Sep 1, 2026 | Kratz Erica · officer: Chief Reg. & Quality Officer | A-Award | 199,115 | $7.43 |
| Sep 1, 2026 | Hopkins Janet Jill · officer: Chief Medical Officer | A-Award | 58,850 | $0.00 |
| Sep 1, 2026 | Hopkins Janet Jill · officer: Chief Medical Officer | A-Award | 116,150 | $7.43 |
| Sep 1, 2026 | Abu-Absi Susan · officer: Chief Operating Officer | A-Award | 265,487 | $7.43 |
| Sep 1, 2026 | Abu-Absi Susan · officer: Chief Operating Officer | A-Award | 134,513 | $0.00 |
| Sep 1, 2026 | Elazzouzi Amy · officer: SVP, Finance & PAO | A-Award | 46,460 | $7.43 |
| Jul 8, 2026 | Bender Jeremy · director | A-Award | 30,000 | $0.00 |
| Jul 8, 2026 | Bender Jeremy · director | A-Award | 60,000 | $7.03 |
| Jul 1, 2026 | Kilroy Conor · officer: See Remarks | A-Award | 14,858 | $0.00 |
| Jun 16, 2026 | Gibney Anthony S · officer: See Remarks | Sale | 12,824 | $6.42 |
| Jun 15, 2026 | Johnson David Michael · director | A-Award | 30,000 | $6.21 |
| Jun 15, 2026 | Mattessich Antony C. · director | A-Award | 15,000 | $0.00 |
| Jun 15, 2026 | Mattessich Antony C. · director | A-Award | 30,000 | $6.21 |
| Jun 15, 2026 | Bitetti Teresa Marie · director | A-Award | 30,000 | $6.21 |
| Jun 15, 2026 | Srivastava Sapna · director | A-Award | 15,000 | $0.00 |
| Jun 15, 2026 | Srivastava Sapna · director | A-Award | 30,000 | $6.21 |
| Jun 15, 2026 | Johnson David Michael · director | A-Award | 15,000 | $0.00 |
| Jun 15, 2026 | Bitetti Teresa Marie · director | A-Award | 15,000 | $0.00 |
| May 19, 2026 | Holles Natalie C. · director, officer: See Remarks | A-Award | 2,169,103 | $7.39 |
| May 19, 2026 | Holles Natalie C. · director, officer: See Remarks | A-Award | 553,844 | $0.00 |
| May 19, 2026 | Holles Natalie C. · director, officer: See Remarks | A-Award | 600,118 | $0.00 |
| May 11, 2026 | Matrix Capital Management Company, LP · 10 percent owner | Sale | 6,922,870 | $5.64 |
| Apr 16, 2026 | Kilroy Conor · officer: See Remarks | Sale | 11,738 | $7.02 |
| Feb 17, 2026 | Plavsic Mark · officer: Chief Technology Officer | Sale | 15,890 | $5.05 |
| Feb 17, 2026 | Kilroy Conor · officer: See Remarks | Sale | 12,079 | $5.05 |
| Feb 17, 2026 | de los Pinos Elisabet · director, officer: See Remarks | Sale | 47,648 | $5.06 |
Institutional positioning
13F filings over the trailing two quarters
New 61Increased 96Reduced 73Sold out 14
| Filer | Action | Shares | Filed |
|---|---|---|---|
| TCG Crossover Management, LLC | New Position | 9,533,333 | Aug 14, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 7,206,217 | Aug 14, 2026 |
| Frazier Life Sciences Management, L.P. | Increased | 7,100,000 | Aug 14, 2026 |
| MATRIX CAPITAL MANAGEMENT COMPANY, LP | Unchanged | 6,922,870 | May 14, 2026 |
| Long Focus Capital Management, LLC | Increased | 5,119,582 | Aug 14, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Unchanged | 5,100,000 | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Unchanged | 4,881,125 | May 15, 2026 |
| BlackRock, Inc. | Increased | 4,707,674 | Aug 7, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Reduced | 4,640,000 | Aug 14, 2026 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | Unchanged | 4,619,582 | May 15, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 4,372,884 | May 15, 2026 |
| Caligan Partners LP | Increased | 4,298,248 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,100,342 | Aug 13, 2026 |
| FCPM III SERVICES B.V. | New Position | 4,053,775 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 3,586,640 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026